
AstraZeneca Pharma India Share Price
₹6,870.30 -105.5 (-1.51%)
22 Feb, 2025 13:10
Start SIP in
ASTRAZEN
Performance
- Low
- ₹6,808
- High
- ₹7,023
- 52 Week Low
- ₹4,785
- 52 Week High
- ₹8,139
- Open Price₹6,979
- Previous Close₹6,976
- Volume6,305
Investment Returns
- Over 1 Month + 1.75%
- Over 3 Month + 8.96%
- Over 6 Month + 3.66%
- Over 1 Year + 25%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 177.1
- PEG Ratio
- -5.8
- Market Cap Cr
- 17,176
- P/B Ratio
- 25.3
- Average True Range
- 286.36
- EPS
- 67.05
- Dividend Yield
- 0.3
- MACD Signal
- 56.7
- RSI
- 37.78
- MFI
- 45.9
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹6,870.30
-105.5
(-1.51%)

-
- Bullish Moving Average 2
-
- Bearish Moving Average 14
- 20 Day
- ₹7,162.52
- 50 Day
- ₹7,093.30
- 100 Day
- ₹6,994.29
- 200 Day
- ₹6,687.50
Resistance and Support
6900.35
- R3 7,207.00
- R2 7,114.80
- R1 6,992.55
- S1 6,778.10
- S2 6,685.90
- S3 6,563.65
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹6,870 As on 22 February, 2025 | 12:56
The Market Cap of AstraZeneca Pharma India is ₹17175.8 Cr As on 22 February, 2025 | 12:56
The P/E ratio of AstraZeneca Pharma India is 177.1 As on 22 February, 2025 | 12:56
The PB ratio of AstraZeneca Pharma India is 25.3 As on 22 February, 2025 | 12:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.